|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease显示文摘 | Hiltunen M Mannermaa A | 2002 | Dement Geriatr Cogn Disord2002，14，3： | 1 |
| 2 | Loss of heterozygosity at chromosomes 3,6,8,11,16,and17in ovarian cancer:correlation to clinicopathological variables显示文摘 | Launonen V1 Mannermaa A Stenbück F | 2000 | Cancer Genet Cytogenet2000，122，1： | 1 |
| 3 | Genome-wide linkage dis- equilibrium mapping of late-onset Alzheimer's disease in Finland 显示文摘 | Hiltunen M Mannermaa A Thompson D | 2001 | Neurology2001，57，9： | 1 |
| 4 | XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer 显示文摘 | Tengstrm M Mannermaa A Kosma V M | 2014 | Anticancer Res2014，34，6： | 1 |
| 5 | Loss of heterozygosity at chromosomes 3,6,8, 11,16, and 17 in ovarian cancer: correlation to clinicopathological variables显示文摘 | Mannermaa A Stenback F | 2000 | Cancer Genet Cytogenet2000，122，： | 1 |
| 6 | XRCC1 rs25487Poly- morphism Predicts the Survival of Patients After Postoperative Radio- therapy and Adjuvant Chemotherapy for Breast Cancer显示文摘 | Tengstrsm M Mannermaa A Kosma VM | 2014 | Anticancer Res2014，34，6： | 1 |
| 7 | Loss of heterozygosi- ty at chromosomes 3,6,8,11,16, and 17 in ovarian cancer: corre- lation to clinicopathological variables显示文摘 | Launonen V Mannermaa A Stenback F | 2000 | Cancer Genet Cytogenet2000，122，1： | 1 |
| 8 | Genome-wide linkage disequilibrium mapping of late-onset Alzheimer′s disease in Finland显示文摘 | Hiltunen M Mannermaa A Thompson D | 2001 | Neurology2001，57，9： | 1 |
| 9 | Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women显示文摘 | Pirskanen M Hiltunen M Mannermaa A | 2005 | European Journal of Human Genetics2005，13，9： | 1 |
| 10 | Drug transport in corneal epithelium and blood-retina barrier:emerging role of transporters in ocular pharmacokinetics显示文摘 | Vellonen KS Urtti A | 2006 | Adv Drug Deliv Rev2006，58，1： | 1 |
| 11 | Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland显示文摘 | Hiltunen M Mannermaa A Thompson D | 2001 | Neurology2001，57，： | 1 |
| 12 | Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydeogenase 2 gene(EDH17B2) using a single-strand conformation polymorphism assay 显示文摘 | Mannermaa A Peltoketo H Winqvist R | 1994 | Hum Genet1994，93，3： | 1 |
| 13 | Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer′s disease family:an Alu core sequence-stimulated recombination显示文摘 | Hiltunen M Helisalmi S Mannermaa A | | 0，，： | 1 |
| 14 | Watersolubleβ-cyclodextrin in paediatric oral solution of spironolactone:solubilization and stability of spironolactone in solutions of β-cyclodextrin derivatives显示文摘 | Kaukonen A M Kilpelainen I Mannermaa J P | 1997 | Int J Pharmaceutics1997，159，： | 1 |
| 15 | Apolipoprotein E pol- ymorphism and Alzheimer' s disease in eastern Finland 显示文摘 | Lehtovirta M Helisalmi S Mannermaa A | 1995 | Neurosci Lett1995，185，1： | 1 |
| 16 | Developing a tool for the preparation of GMP audit of pharmaceutical contract manufacturer显示文摘 | Linna A Korhonen M Mannermaa JP | 2008 | Euro J Pharm Biopharma2008，，69： | 1 |
| 17 | Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland 显示文摘 | Hiltunen M Mannermaa A Thompson D | 2001 | Neurology2001，57，9： | 1 |
| 18 | Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation显示文摘 | Kallinen J Heinonen S Mannermaa A Ryynanen M | 2000 | Clin Genet2000，58，2： | 1 |
| 19 | Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland显示文摘 | Lehtovirta M Helicalmi S Mannermaa A | 1995 | Neurosci Lett1995，185，： | 1 |
| 20 | Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmaeokinefics显示文摘 | Mannermaa E Vellonen KS Urtti A | 2006 | Adv Drug Deliv Rev2006，58，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员